Embed Size (px)
Citation preview
Hong Kong’s Biomedical Technology Ecosystem
George Tee Chief Technology Officer Hong Kong Science and Technology Parks Corpora<on
January 2019
Hong Kong Science Park: Innova<on, Technology, Entrepreneurship
Hong Kong Science Park: Innova<on, Technology, Entrepreneurship
330,000 m2 R&D Office Space
Officially opened in 2002
700 Tech Enterprises
11,000 working popula<on
Leading Technology Incubator in town with
240
start-‐ups in programmes
22 Na<onali<es of Park Companies
Hong Kong’s I&T hub together
with InnoCentre and Industrial Estates
Sha7n Kowloon Tong Taipo Yuen Long
Tseung Kwan O
Science Park Research & Development
Industrial Estates
Manufacturing
InnoCentre Design & Fintech
*Updated in December 2018
Innova<on as the Backbone – Key Technology Focus
Healthcare Technologies
Smart Ci<es
FinTech
Ar<ficial Intelligence &
Robo<cs
HKSTP’s Technology Clusters Technology Focus Areas
Biomedical Technology
Material & Precision
Engineering
Green Technology
Informa<on & Communica<on Technology (ICT)
Electronics
HKSTP Key Achievements – 17 Years, and 2018
*Updated in September 2018
1st Unicorn
Successfully built partnerships with 60 corpora<ons: Airport Authority, CLP, Maxim’s, Ocean Park, New World, HKT, Hutchison, HKJC, MTR
Companies expanded into China, regional and globally, with HKSTP’s support
Investment Raised…FY17/18
Fund raised for all Park companies $153 M USD 6X Fund raised for incubatees and graduates in
17/18 compared to 16/17
577 Graduated from Incuba<on Programmes since incep<on 440 S<ll in
Business 4 Completed IPOs
Incuba<on – Incu-‐App, Incu-‐Tech, Incu-‐Bio…so far
ITF
Partner Companies
Universities
Private Equity / Venture Capital
Strategic Corporate Partners
Research Institutes
Government & Industry Associa=ons
Business matching
Sponsored accelera=on programs
Funding / Investment
Talent Technologies Transfer
Sharing Facili=es
Standards, advocacy & influence in regula=ons and adop=on
HKSTP – a plaHorm for Innova=on & Technology Ecosystem
Biomedical Technology Cluster @HKSTP
Ø 110+ Partner Companies and Incubatees Ø 1,000+ researchers from 12 countries
Others
Diagnos7cs
Medical Devices
Pharmaceu7cs
Stem Cell & Regenera7ve Medicine
Tradi7onal Chinese Medicine
Sub-‐cluster Distribu7on (Partner Companies)
Partner Companies
and Incubatees
Diagnos7cs Medical Devices
Pharmaceu7cs
Tradi7onal Chinese Medicine Stem Cell & Regenera7ve Medicine
Others
《2018/2019 Government Budget》 Focus on Innova7on & Technology
Bio Tech A.I. & Robo7cs
Smart City Fintech
USD 6.4 Billion
《2018/2019 Government Budget》 Focus on Innova7on & Technology
First phase of the HK-‐SZ Innova7on and Technology Park in the Lok Ma Chau Loop
§ CyberPort § Technology Talent Scheme
§ Postdoctoral Hub
§ Healthcare Technologies
§ A.I. & Robo=cs
• Research-‐related Infrastructure and Facili<es
• Strengthened support measures for Park companies
§ Innova=on and Technology Fund (ITF)
2.55B HK SZ
I&T Park
1.28B ITF
63.9M Talents
1.28B Science
Park
1.28B Two
Research Clusters
38.3M CyberPort
USD 6.4+ Billion
Bio Tech A.I. & Robo7cs
Smart City Fintech
Figures in USD
Future Development – USD 1.28B Funding
Item
Es7mated Cost (USD$ million)
1 Expansion of Incuba=on Programmes 307
2 Support for Tenants 383
3 Accommoda=on Support 12
4 Expansion of CVF 64
5 Smart Campus 38
6 Ancillary Facili=es 69
7 Provision of lab spaces for healthcare and AI and robo=cs technologies researches
59
8 Facili=es for healthcare, AI and robo=cs technologies researches
345
TOTAL: 1277
Three Focus Areas:
• Strengthen support for local and overseas start-‐ups and technology companies and a`ract them to join the ecosystem
• Provide a full range of value-‐added services, including fund raising and go-‐to-‐market support, etc.
• Enhance and set up exis=ng and new research and development facili=es to meet market and industry needs
• 4-‐year program • All rounded support • USD 510K + 255K subsidy Professional
Coaching
Fund-‐raising & Financial support
Shared Equipment & Facili=es
Talents
Objec7ves
• Growth : Offering 1-‐stop biomedical technology focused services to startups
• Commercializa7on: Assis=ng transla=on of research, tapping into the Asian/Chinese market
• Financial Sustainability : Providing capital (subsidy, investment) to support startups through the “Valley of Death”
Professional Services
Regulatory Support
Incu-Bio Program
BMT Ecosystem / Industry
Talent Acquisi<on Support
Max. monthly allowance: ~USD $2,400
Max. monthly allowance: ~USD $4,000
Bachelor / Master degree from local university
Doctoral degree from local university or well-‐recognised non-‐local
ins7tu7on
Internship Programme
Postdoctoral Hub
• Postdoctoral Hub Programme (PH-‐SPC) under Technology Talent Scheme (NEW)
• Internship Programme (IP-‐SPC) • Technology Talent Admission Scheme
(TechTAS)
HKSP Incubatees and Partner Companies
Max. 2 interns + 2 postdocs at any
one 7me (Max. 24 mnths)
Deal Flows Transaction Support Over 600 Companies
Tenants Global Acceleration Academy
LEAP Universities
Research Institute Co-working Spaces
Multi-Channel Fundraising
HKSTP network HKBAN VIAHK
天使匯中國⻘青年天使會
Roadshow, Matching, Events, Community
Comprehensive Advisory
HKSTP Investment Team Professional Clinic
Lawyers, CPAs, IP Specialists Marketing Consultants etc.
Training, Coaching, Consulting
HKSTP Investment Service Platform
Investment Raised…FY17/18 USD 153m
USD 86.0m USD 6.4m is Committed by CVF
:
HKSTP Corporate Venture Funds
is Raised
Fund I
Fund II USD 25.0m Additional fund to invest into startups in HKSTP
A co-investment fund focusing on Seed to Series A investment in HKSTP companies
Biomedical Technology (BMT)
Information & Communication
Technology (ICT) Electronics
Material & Precision Engineering
Green Technology
1 13.4
Others USD 40+m Other investment modes to support the ecosystem
Labs and Services Support Biomedical Technology Support Centre (BSC)
• Area: 8,900 sq.i. • Nature: co-‐working space • 23 offices ranging from 100-‐150 sq.i. • 20 floa=ng desks • Product prototype tes=ng room (~800 sq.i.) • 15 companies moved in (70-‐80% occupancy rate)
Healthcare Devices Innova7on Hub (HDIH)
• Area: 8,700 sq.i. • Nature: communal lab • 80+ pieces of ready-‐to-‐use life science instruments for shared
R&D use • Culture Room, Freeze Dryer Room, Mass Spectrometry Lab,
Microscope Room, Genomics Lab, Proteomics Lab, Bioanalysis Lab, Microbiology Lab …
Translational Research Facilities
GLP Biosamples repository Support biomarker discovery and efficacy analyses
Secured and centralized Data plaHorm for R&D Data management, analy=cs, sharing
GMP Facility for drug materials (Biologics & Cell processing) Provide GMP drug quality assessment for every stage of clinical trials Device standard cer=fica=on facility
Bench Transla'onal Research Bedside
Biobank Biomedical Informa7cs Drug Safety Center Pilot Batch /
Device Tes7ng
GLP Drug Safety Center for drug efficacy Provide GLP in vitro and in vivo drug safety and toxicology assessment
Medical database and informa7on exchange
Globally recognized clinical trial centers
Unique pa7ent profiles and pathologies
Capitalize These Advantages in Biomedical Technology in Hong Kong
Pre-‐revenue IPO for Biotech chapter
• Incubators
Golden Opportunity for:
• Investors
• Industry Partners
• Startups/Companies
• Ins'tutes
• Talents
Thank you
![[20160305][HKSTP Career Fair][Recruitment Talk]](https://img.pdfslide.net/doc/110x75/58eebea71a28ab60468b4613/20160305hkstp-career-fairrecruitment-talk.jpg)
